{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T12:48:38Z","timestamp":1790772518530,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Uniwersytet Medyczny w Lodzi","doi-asserted-by":"publisher","award":["503\/3-011-02\/503-31-002"],"award-info":[{"award-number":["503\/3-011-02\/503-31-002"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.biopha.2023.115843","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T18:48:52Z","timestamp":1699296532000},"page":"115843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"special_numbering":"C","title":["The current state of preclinical modeling of human diabetic cardiomyopathy using rodents"],"prefix":"10.1016","volume":"168","author":[{"given":"Magdalena","family":"Jasi\u0144ska-Stroschein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"27","key":"10.1016\/j.biopha.2023.115843_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehv134","article-title":"Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes","volume":"36","author":"Seferovi\u0107","year":"2015","journal-title":"Eur. Heart J."},{"issue":"1","key":"10.1016\/j.biopha.2023.115843_bib2","doi-asserted-by":"crossref","first-page":"H113","DOI":"10.1152\/ajpheart.00440.2018","article-title":"Right ventricular dysfunction and remodeling in diabetic cardiomyopathy","volume":"316","author":"Kang","year":"2019","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115843_bib3","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/1479164118787415","article-title":"The prevalence of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction in men and women with type 2 diabetes: a systematic review and meta-analysis","volume":"15","author":"Bouthoorn","year":"2018","journal-title":"Diab Vasc. Dis. Res"},{"issue":"4","key":"10.1016\/j.biopha.2023.115843_bib4","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCRESAHA.117.311586","article-title":"Diabetic cardiomyopathy: an update of mechanisms contributing to this clinical entity","volume":"122","author":"Jia","year":"2018","journal-title":"Circ. Res"},{"issue":"9","key":"10.1016\/j.biopha.2023.115843_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/s41569-020-0339-2","article-title":"Mechanisms of diabetic cardiomyopathy and potential therapeutic strategies: preclinical and clinical evidence","volume":"17","author":"Tan","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"issue":"36","key":"10.1016\/j.biopha.2023.115843_bib6","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"issue":"17","key":"10.1016\/j.biopha.2023.115843_bib7","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/heartjnl-2021-319605","article-title":"Heart failure with preserved ejection fraction: recent concepts in diagnosis, mechanisms and management","volume":"108","author":"Gevaert","year":"2022","journal-title":"Heart"},{"key":"10.1016\/j.biopha.2023.115843_bib8","first-page":"cvac152","article-title":"The need for adjusting experimental models to meet clinical reality","author":"Lezoualc'h","year":"2022","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.biopha.2023.115843_bib9","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/1471-2288-14-43","article-title":"SYRCLE's risk of bias tool for animal studies","volume":"14","author":"Hooijmans","year":"2014","journal-title":"BMC Med Res Method."},{"issue":"6","key":"10.1016\/j.biopha.2023.115843_bib10","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jacbts.2017.07.013","article-title":"Murine models of heart failure with preserved ejection fraction: a \"fishing expedition\"","volume":"2","author":"Valero-Mu\u00f1oz","year":"2017","journal-title":"JACC Basic Transl. Sci."},{"issue":"12","key":"10.1016\/j.biopha.2023.115843_bib11","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/01.RES.0000129254.25507.d6","article-title":"What mechanisms underlie diastolic dysfunction in heart failure","volume":"94","author":"Kass","year":"2004","journal-title":"Circ. Res"},{"key":"10.1016\/j.biopha.2023.115843_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113251","article-title":"Searching for an experimental rodent model of heart failure with preserved ejection fraction: Re-visited","volume":"152","author":"Jasi\u0144ska-Stroschein","year":"2022","journal-title":"Biomed. Pharm."},{"issue":"2","key":"10.1016\/j.biopha.2023.115843_bib13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2337\/dc12-0474","article-title":"Right ventricular involvement in diabetic cardiomyopathy","volume":"36","author":"Widya","year":"2013","journal-title":"Diabetes Care"},{"issue":"12","key":"10.1016\/j.biopha.2023.115843_bib14","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1113\/EP089516","article-title":"Histological and haemodynamic characterization of right ventricle in sedentary and trained rats with heart failure with preserved ejection fraction","volume":"106","author":"Oliveira","year":"2021","journal-title":"Exp. Physiol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115843_bib15","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1161\/ATVBAHA.119.313883","article-title":"Treatment with treprostinil and metformin normalizes hyperglycaemia and improves cardiac function in pulmonary hypertension associated with heart failure with preserved ejection fraction","volume":"40","author":"Wang","year":"2020","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115843_bib16","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1253\/circj.70.327","article-title":"Left ventricular dysfunction and remodeling in streptozotocin-induced diabetic rats","volume":"70","author":"Nemoto","year":"2006","journal-title":"Circ. J."},{"issue":"5","key":"10.1016\/j.biopha.2023.115843_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0232399","article-title":"Both male and female obese ZSF1 rats develop cardiac dysfunction in obesity-induced heart failure with preserved ejection fraction","volume":"15","author":"Nguyen","year":"2020","journal-title":"PLoS One"},{"issue":"16","key":"10.1016\/j.biopha.2023.115843_bib18","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1161\/CIRCULATIONAHA.105.587519","article-title":"Myocardial structure and function differ in systolic and diastolic heart failure","volume":"113","author":"van Heerebeek","year":"2006","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.biopha.2023.115843_bib19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/CIRCULATIONAHA.117.031358","article-title":"Visceral adipose tissue drives cardiac aging through modulation of fibroblast senescence by osteopontin production","volume":"138","author":"Sawaki","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.biopha.2023.115843_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12872-015-0154-6","article-title":"Administration of granulocyte-colony stimulating factor accompanied with a balanced diet improves cardiac function alterations induced by high fat diet in mice","volume":"15","author":"Daltro","year":"2015","journal-title":"BMC Cardiovasc Disord."},{"issue":"2","key":"10.1016\/j.biopha.2023.115843_bib21","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jacc.2017.05.029","article-title":"Arterial stiffening with exercise in patients with heart failure and preserved ejection fraction","volume":"70","author":"Reddy","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.biopha.2023.115843_bib22","doi-asserted-by":"crossref","first-page":"2902351","DOI":"10.1155\/2016\/2902351","article-title":"An overview of murine high fat diet as a model for type 2 diabetes mellitus","volume":"2016","author":"Heydemann","year":"2016","journal-title":"J. Diabetes Res"},{"issue":"4","key":"10.1016\/j.biopha.2023.115843_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060931","article-title":"Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy","volume":"8","author":"Calligaris","year":"2013","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.biopha.2023.115843_bib24","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1159\/000449324","article-title":"Longitudinal changes in measured glomerular filtration rate, renal fibrosis and biomarkers in a rat model of type 2 diabetic nephropathy","volume":"44","author":"Su","year":"2016","journal-title":"Am. J. Nephrol."},{"issue":"12","key":"10.1016\/j.biopha.2023.115843_bib25","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.cardfail.2014.09.001","article-title":"Murine models of diastolic dysfunction and heart failure with preserved ejection fraction","volume":"20","author":"Horgan","year":"2014","journal-title":"J. Card. Fail"},{"issue":"3","key":"10.1016\/j.biopha.2023.115843_bib26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/nrendo.2017.161","article-title":"Animal models of obesity and diabetes mellitus","volume":"14","author":"Kleinert","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"issue":"2 Pt 2","key":"10.1016\/j.biopha.2023.115843_bib27","first-page":"R725","article-title":"Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats","volume":"273","author":"Levin","year":"1997","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.biopha.2023.115843_bib28","first-page":"274","article-title":"Streptozotocin as a tool for induction of rat models of diabetes: a practical guide","volume":"22","author":"Ghasemi","year":"2023","journal-title":"EXCLI J."},{"issue":"6","key":"10.1016\/j.biopha.2023.115843_bib29","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1248\/bpb.29.1110","article-title":"Strain differences in the diabetogenic activity of streptozotocin in mice","volume":"29","author":"Hayashi","year":"2006","journal-title":"Biol. Pharm. Bull."},{"issue":"11","key":"10.1016\/j.biopha.2023.115843_bib30","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.tips.2022.04.005","article-title":"Current landscape of preclinical models of diabetic cardiomyopathy","volume":"43","author":"Prakoso","year":"2022","journal-title":"Trends Pharm. Sci."},{"issue":"2","key":"10.1016\/j.biopha.2023.115843_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1007\/s00210-020-01979-y","article-title":"Cardioprotective effect of pioglitazone and curcumin against diabetic cardiomyopathy in type 1 diabetes mellitus: impact on CaMKII\/NF-\u03baB\/TGF-\u03b21 and PPAR-\u03b3 signaling pathway","volume":"394","author":"Gbr","year":"2021","journal-title":"Naunyn Schmiede Arch. Pharm."},{"issue":"16","key":"10.1016\/j.biopha.2023.115843_bib32","doi-asserted-by":"crossref","first-page":"7642","DOI":"10.1111\/jcmm.16601","article-title":"Dapagliflozin alleviates cardiac fibrosis through suppressing EndMT and fibroblast activation via AMPK\u03b1\/TGF-\u03b2\/Smad signalling in type 2 diabetic rats","volume":"25","author":"Tian","year":"2021","journal-title":"J. Cell Mol. Med"},{"issue":"2","key":"10.1016\/j.biopha.2023.115843_bib33","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1113\/expphysiol.2008.044800","article-title":"Myocardial overexpression of adenine nucleotide translocase 1 ameliorates diabetic cardiomyopathy in mice","volume":"94","author":"Wang","year":"2009","journal-title":"Exp. Physiol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115843_bib34","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1038\/s41467-020-15983-6","article-title":"SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.biopha.2023.115843_bib35","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1042\/CS20150204","article-title":"Impaired mitochondrial energy supply coupled to increased H2O2 emission under energy\/redox stress leads to myocardial dysfunction during Type I diabetes","volume":"129","author":"Tocchetti","year":"2015","journal-title":"Clin. Sci."},{"issue":"4","key":"10.1016\/j.biopha.2023.115843_bib36","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.2040-1124.2012.00202.x","article-title":"Chymase inhibition prevents myocardial fibrosis through the attenuation of NOX4-associated oxidative stress in diabetic hamsters","volume":"3","author":"Maeda","year":"2012","journal-title":"J. Diabetes Invest."},{"issue":"7","key":"10.1016\/j.biopha.2023.115843_bib37","doi-asserted-by":"crossref","first-page":"7609","DOI":"10.1007\/s11033-012-1595-y","article-title":"Improvement of myocardial glycolipid metabolic disorder in diabetic hamster with Astragalus polysaccharides treatment","volume":"39","author":"Chen","year":"2012","journal-title":"Mol. Biol. Rep."},{"issue":"Suppl 1","key":"10.1016\/j.biopha.2023.115843_bib38","first-page":"35","article-title":"Beneficial effects of astragalus polysaccharides treatment on cardiac chymase activities and cardiomyopathy in diabetic hamsters","volume":"47","author":"Chen","year":"2010","journal-title":"Acta Diabetol."},{"issue":"1","key":"10.1016\/j.biopha.2023.115843_bib39","doi-asserted-by":"crossref","first-page":"H176","DOI":"10.1152\/ajpheart.00058.2022","article-title":"Guidelines on models of diabetic heart disease","volume":"323","author":"Heather","year":"2022","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223016414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223016414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T21:09:27Z","timestamp":1779916167000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223016414"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":39,"alternative-id":["S0753332223016414"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115843","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The current state of preclinical modeling of human diabetic cardiomyopathy using rodents","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115843","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115843"}}